These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21730004)

  • 1. Targeted therapy of non-small-cell lung carcinoma.
    Tiwari D; Brodie SA; Brandes JC
    Ther Adv Respir Dis; 2012 Feb; 6(1):41-56. PubMed ID: 21730004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted therapies for non-small cell lung cancer.
    Dempke WC; Suto T; Reck M
    Lung Cancer; 2010 Mar; 67(3):257-74. PubMed ID: 19914732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-small cell lung cancer: from targeted therapy to tailored therapy.
    Malgieri S; Feliciano S; Bosso D; Federico P; Palmieri G; De Placido S; Di Lorenzo G; Buonerba C
    Expert Opin Pharmacother; 2012 Sep; 13(13):1817-9. PubMed ID: 22803703
    [No Abstract]   [Full Text] [Related]  

  • 4. Preclinical strategies targeted at non-small-cell lung cancer signalling pathways with striking translational fallout.
    Favoni RE; Alama A
    Drug Discov Today; 2013 Jan; 18(1-2):11-24. PubMed ID: 22885521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agents in the preclinical development stage for non-small cell lung cancer.
    Sacco PC; Sgambato A; Casaluce F; Maione P; Rossi A; Palazzolo G; Napolitano A; Gridelli C
    Expert Rev Anticancer Ther; 2015; 15(11):1361-6. PubMed ID: 26485341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemetrexed for the treatment of non-small-cell lung cancer.
    Manegold C; Schmid-Bindert G; Pilz LR
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1195-209. PubMed ID: 19761423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer in the era of targeted therapy: a cytologist's perspective.
    Zakowski MF
    Arch Pathol Lab Med; 2013 Dec; 137(12):1816-21. PubMed ID: 23597048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.
    Crawford J
    J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S78-86. PubMed ID: 19795580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New targets for non-small-cell lung cancer therapy.
    Alvarez M; Roman E; Santos ES; Raez LE
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1423-37. PubMed ID: 17944567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted therapy for non-small cell lung cancer.
    Toloza EM; D'Amico TA
    Semin Thorac Cardiovasc Surg; 2005; 17(3):199-204. PubMed ID: 16253823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized medicine for non-small-cell lung cancer.
    Mok TS; Zhou Q; Leung L; Loong HH
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1601-11. PubMed ID: 20942631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in chemotherapy for lung cancer.
    Lilenbaum RC
    Curr Opin Pulm Med; 1996 Jul; 2(4):285-9. PubMed ID: 9363153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention.
    El-Nikhely N; Larzabal L; Seeger W; Calvo A; Savai R
    Expert Opin Investig Drugs; 2012 Aug; 21(8):1107-22. PubMed ID: 22667993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights for IL-6 targeted therapy as an adjuvant treatment for non-small-cell lung cancer.
    Zarogoulidis P; Yarmus L; Zarogoulidis K
    Ther Deliv; 2013 Oct; 4(10):1221-3. PubMed ID: 24116905
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of EGFR inhibition in the treatment of non-small cell lung cancer.
    Ray M; Salgia R; Vokes EE
    Oncologist; 2009 Nov; 14(11):1116-30. PubMed ID: 19892771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy in cancer of the lung].
    Gütz S
    MMW Fortschr Med; 2006 Jun; 148(22):33-4. PubMed ID: 16821578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second and third line treatment in non-small cell lung cancer.
    Favaretto A; Pasello G; Magro C; Schettino C; Gridelli C
    Crit Rev Oncol Hematol; 2009 Aug; 71(2):117-26. PubMed ID: 19249227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and emerging medical treatments for non-small cell lung cancer: a primer for pulmonologists.
    Mazzone P; Mekhail T
    Respir Med; 2012 Apr; 106(4):473-92. PubMed ID: 22119173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evidence on the undertreatment of older and poor performance patients who have advanced non-small-cell lung cancer: is there a role for targeted therapy in these cohorts?
    Langer CJ
    Clin Lung Cancer; 2011 Sep; 12(5):272-9. PubMed ID: 21704567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.